You have a cabinet shelf with three supplements on it that did nothing. A maca capsule someone on Instagram recommended. A “female vitality” blend from a brand you cannot remember. Something with ashwagandha that was supposed to fix everything and fixed nothing. You are looking at Ristela and wondering whether this is number four on the shelf — or whether this one is actually different.
That is a fair question. And most supplement reviews will not answer it honestly because they are written to sell you the product, not to help you decide. This review leads with the evidence. It tells you exactly what Ristela is, what the clinical trials showed, who it is designed for, and — just as importantly — who it is not designed for. If you are new to the topic of desire loss during menopause and want to understand why it happens before evaluating a product, start with our guide to low libido during menopause. We also introduced Ristela briefly in our non-hormonal treatment overview. This is the full review.
What Ristela Is and How It Is Supposed to Work
First, the regulatory distinction that matters. Ristela is a dietary supplement, not an FDA-approved drug. That does not make it ineffective — but it means the evidence standard is different. Dietary supplements are regulated under DSHEA (the Dietary Supplement Health and Education Act). They are not required to prove efficacy before sale the way pharmaceutical drugs are. They can be “clinically studied” — meaning published clinical trials exist evaluating their ingredients — but they cannot accurately be called “clinically proven” in the way that term applies to FDA-approved treatments. This distinction is worth knowing before you evaluate the evidence.
Ristela is manufactured by Bonafide Health. Each serving (two tablets daily) contains four active ingredients working through the nitric oxide pathway:
- Pycnogenol (French maritime pine bark extract) — 80 mg: A standardised antioxidant extract that stimulates nitric oxide synthase, promoting vasodilation and increased blood flow. Also has documented antioxidant and anti-inflammatory properties.
- L-arginine — 800 mg: An amino acid that serves as a direct precursor to nitric oxide. L-arginine is converted to nitric oxide by endothelial nitric oxide synthase, supporting vasodilation.
- L-citrulline — amount not publicly disclosed: An amino acid that recycles into L-arginine, sustaining nitric oxide production over a longer window than L-arginine alone.
- Rose hip extract — amount not publicly disclosed: Included as an antioxidant support ingredient.
The combined mechanism: increased nitric oxide production leads to enhanced blood flow to genital tissues during the sexual response. This is a vascular mechanism, not a hormonal one. Ristela does not contain hormones and does not have estrogen receptor activity.
What the Clinical Evidence Actually Shows
This article contains affiliate links. StillHer may earn a commission if you purchase through the links below, at no extra cost to you. This does not affect our editorial recommendations or evidence assessment.
Ristela’s clinical evidence comes from three published RCTs using the Lady Prelox formula — the same active ingredient combination marketed as Ristela in the United States:
Trial 1: Bottari et al., Panminerva Med, 2012 (n=83 postmenopausal women). 60.8% improvement in overall FSFI score versus 7.5% in placebo over 8 weeks. Arousal, orgasm, and sexual satisfaction all improved significantly.
Trial 2: Stanislavov & Rohdewald, J Sex Marital Ther, 2015 (n=100). Significant improvement in FSFI scores across arousal, orgasm, and satisfaction domains over 8 weeks.
Trial 3: An additional manufacturer-reported study (n=80) with consistent direction of effect across FSFI domains.
Where the evidence has limits: The primary endpoint in these trials was overall FSFI score, not desire or libido specifically. Desire is one component of the FSFI, but it was not isolated as a standalone outcome. The sample sizes are modest (83, 80, and 100 women). The longest trial was 8 weeks — long-term efficacy data are not available. And the evidence comes from manufacturer-associated research, not independent replication. This does not mean Ristela does not work. It means the evidence is real but not definitive, and honest reviewers should say so.
Who Ristela Is Right For (And Who It Is Not)
Ristela May Be Worth Trying If…
You are a perimenopausal or postmenopausal woman whose primary concern is difficulty becoming physically aroused, reduced orgasm intensity or frequency, or a general decline in sexual satisfaction — and you want a non-prescription, non-hormonal starting point before considering hormonal therapy. You are sexually active (or willing to be during the trial period — Ristela is not an on-demand treatment, and the trials required sexual activity to measure outcomes). You have already addressed contributing factors like severe sleep disruption, untreated depression, or relationship conflict. You understand that this is a supplement with moderate clinical evidence, not a guaranteed solution, and you are willing to commit to consistent daily use for at least 8 weeks before evaluating results.
If the profile above matches your situation — difficulty with arousal or orgasm as the primary concern, non-prescription preference, willingness to commit to 8 weeks — this is a reasonable starting point with more clinical evidence behind it than most supplements in this space.
Ristela Is Probably Not the Right Starting Point If…
Your primary symptom is vaginal dryness. Ristela does not treat vaginal dryness or tissue atrophy. Its mechanism is vascular (blood flow), not tissue hydration. If dryness is your primary concern, you need a vaginal moisturiser — start with our guide to vaginal dryness during menopause or our Revaree vs Replens comparison.
Your primary symptom is painful sex. Ristela does not address dyspareunia. Painful sex during menopause is typically caused by tissue atrophy, reduced lubrication, and pelvic floor dysfunction — none of which Ristela targets. Start with our guide to painful sex during menopause.
You have significant hormonal deficiency and your desire loss is severe. If your testosterone levels are well below the physiological range and you are experiencing profound absence of desire alongside other hormonal symptoms, you may need hormonal therapy before a supplement can move the needle. Talk to a menopause-certified provider about testosterone — our libido guide covers the evidence and off-label status.
Your low desire is primarily relational or psychological. If the issue is fundamentally about the relationship, unresolved conflict, or depression — no supplement will fix that. A sex therapist or couples counsellor specialising in menopause-related sexual health is the right tool. This is not failure. It is choosing the right intervention for the right problem.
These redirects are not caveats. They are the reason this review is honest. Ristela is a specific product for a specific problem. If it is not your problem, I would rather you find the right solution than buy the wrong one.
The Practical Details
Dosing: Two tablets once daily, with or without food. This is not an on-demand product. Take daily and consistently.
Onset: Clinical trials showed measurable improvement in arousal and orgasm at 4 weeks, with continued improvement through 8 weeks. Bonafide recommends consistent use for at least 2 months for best results.
Duration: This is an ongoing supplement, not a short-term course. Benefits are maintained with continued use. The effects are not permanent — they depend on continued supplementation.
Cost: Approximately $48/month on a monthly subscription directly from Bonafide. A 3-month plan reduces the cost to approximately $43/month ($129 per quarter). A single one-time purchase box is approximately $58. Also available on Amazon and at Target. HSA/FSA eligible through Bonafide’s Truemed partnership (eligibility varies).
Side effects: In clinical trials, side effects reported with Ristela were comparable to those reported with placebo. No serious adverse events were documented across any trial. The ingredients have been used by women in Europe under the Lady Prelox brand for over 20 years.
Available directly from Bonafide with subscription options, or at Amazon and Target for one-time purchase. Commit to 8 weeks of consistent use before evaluating results.
Samantha’s Verdict
Ristela is an evidence-informed, non-prescription supplement for women whose primary concern is difficulty with arousal, orgasm, or overall sexual satisfaction during menopause. It is not a replacement for hormonal therapy in women with significant testosterone deficiency. It is not a treatment for vaginal dryness or painful sex. It is not a guaranteed solution. It is a specific tool for a specific problem — and for the right candidate, it has more clinical evidence behind it than nearly any other non-prescription supplement in this space.
The evidence grade is moderate. Three RCTs with consistent direction, manufacturer-associated but published in peer-reviewed journals, with real effect sizes on real endpoints. The primary mechanism is arousal, not desire — but for many women, the path to reconnecting with desire runs through the body first. If your body responds more easily, your brain often follows.
If the candidate profile in the section above matches your situation, I think Ristela is a reasonable first step. If it does not match, I have pointed you to the article that does. That is what honest reviews do.
Non-hormonal. Clinically studied. Moderate evidence grade. For women whose primary concern is arousal and sexual satisfaction during menopause — not dryness, not pain, not severe hormonal deficiency. 8 weeks of consistent daily use. That is the honest recommendation.
For the women who have bought three supplements that did nothing: this review was written so the next one is a more informed choice. Whether that choice is Ristela or something else entirely, you deserve to make it with real information.